Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001738048-25-000005
Filing Date
2025-11-07
Accepted
2025-11-07 16:38:30
Documents
4

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 16899
2 POWER OF ATTORNEY FOR BONG KOH ex-24-11072025_091135.htm EX-24.1 5449
3 POWER OF ATTORNEY FOR NIMISH SHAH ex-24-11072025_091136.htm EX-24.2 5458
4 JOINT FILING AGREEMENT ex-99-11072025_091137.htm EX-99.1 6639
  Complete submission text file 0001738048-25-000005.txt   36141
Mailing Address 530 FIFTH AVENUE, 22ND FLOOR NEW YORK NY 10036
Business Address 530 FIFTH AVENUE, 22ND FLOOR NEW YORK NY 10036 212-444-4100
Venrock Healthcare Capital Partners III, L.P. (Filed by) CIK: 0001738048 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 100 KING STREET WEST SUITE 5600 TORONTO A6 M5X 1C9
Business Address 100 KING STREET WEST SUITE 5600 TORONTO A6 M5X 1C9 (908) 764-8385
CYBIN INC. (Subject) CIK: 0001833141 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: SCHEDULE 13G | Act: 34 | File No.: 005-93441 | Film No.: 251463230
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)